Cerity Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Cerity Partners's JNJ Position: Q1 2026 in Review
Cerity Partners increased its Johnson & Johnson (JNJ) stake by 2.2% in Q1 2026, buying an estimated $9.23M and bringing the position to 1,846,524 shares worth $451M. The position accounts for 0.64% of the portfolio, ranked #25.
Cerity Partners first reported a position in JNJ in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.7B in Q1 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Cerity Partners held 1,846,524 shares of Johnson & Johnson worth $451M as of Q1 2026.
- Cerity Partners bought 39,639 Johnson & Johnson shares in Q1 2026, an estimated $9.23M.
- Johnson & Johnson made up 0.64% of Cerity Partners's portfolio in Q1 2026, its #25 holding.
- Cerity Partners first reported a position in Johnson & Johnson in Q4 2016 and has held it in 38 quarters since.
- Cerity Partners's Johnson & Johnson position peaked at $1.7B in Q1 2023.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.